During the past decade, Minsk city Clinical Oncological Dispensary conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Minsk city Clinical Oncological Dispensary" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Axelar AB" with 1 trials sponsored, "Bayer" with 1 trials sponsored, "BeiGene" with 1 trials sponsored and "EirGenix, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Minsk city Clinical Oncological Dispensary" #1 collaborator was "PSI CRO" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Minsk city Clinical Oncological Dispensary" are "Adenocarcinoma of the Lung" (1 trials), "Blood Cancer" (1 trials), "Breast Cancer" (1 trials), "Cancer" (1 trials) and "Chemotherapy-Induced Nausea and Vomiting" (1 trials). Many other conditions were trialed in "Minsk city Clinical Oncological Dispensary" in a lesser frequency.

Most popular intervention types in "Minsk city Clinical Oncological Dispensary" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "AXL1717" (1 trials), "Abiraterone acetate (AA)" (1 trials), "Bevacizumab" (1 trials) and "Cetrelimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Minsk city Clinical Oncological Dispensary" are 6 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Minsk city Clinical Oncological Dispensary". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Minsk city Clinical Oncological Dispensary, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Minsk city Clinical Oncological Dispensary, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".